(206 days)
Not Found
No
The document describes a standard C-arm X-ray system with image processing capabilities, but there is no mention of AI or ML in the device description, intended use, or performance studies. The performance studies focus on compliance with standards and image quality compared to a predicate device, not on AI/ML performance metrics.
No.
The device is described as an X-ray system used for "radiological guidance and visualization during diagnostic, interventional, and surgical procedures," which points to its use for diagnostic imaging rather than direct therapeutic treatment.
Yes
The "Intended Use / Indications for Use" section states that the device is used for “radiological guidance and visualization during diagnostic, interventional, and surgical procedures.” The inclusion of "diagnostic" indicates that the device has a diagnostic function.
No
The device description explicitly states it is a "counterbalanced C-arm with a thin flat detector x-ray system" and lists hardware components like the C-arm stand, X-ray generator, X-ray tube, Flat Detector, and mobile viewing station. This indicates it is a hardware device with integrated software, not a software-only medical device.
Based on the provided information, the Veradius device is not an IVD (In Vitro Diagnostic) device.
Here's why:
- IVD devices are used to examine specimens from the human body. The Veradius device is an X-ray system used for radiological guidance and visualization during diagnostic, interventional, and surgical procedures directly on patients. It does not analyze biological samples.
- The description focuses on imaging and procedural guidance. The device description details the C-arm, X-ray components, image processing, and viewing station, all of which are characteristic of medical imaging and procedural guidance systems, not IVD devices.
- The intended use and applications are clinical procedures. The listed applications (Orthopedic, Neuro, Abdominal, Vascular, Thoracic, Cardiac) are all areas where medical imaging is used for diagnosis and intervention on the patient.
Therefore, the Veradius device falls under the category of a medical imaging and procedural guidance device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Veradius device is intended to be used and operated by: adequately trained, qualified, and authorized health care professionals such as physicians, surgeons, cardiologists, and radiographers. who have full understanding of the safety information and emergency procedures as well as the capabilities and functions of the device. The device is used for radiological guidance and visualization during diagnostic, interventional, and surgical procedures on all patients except neonates (birth to 1 month), within the limits of the device is to be used in health care facilities both inside and outside the operating room. in sterile as well as nonsterile environments, in a variety of procedures.
Applications
- Orthopedic
- Neuro
- Abdominal
- : Vascular
- Thoracic
- Cardiac
Product codes
OWB, JAA
Device Description
The proposed Veradius R1.2 is a counterbalanced C-arm with a thin flat detector x-ray system. The system consists of two main component parts: the C-arm stand (comprising X-ray generator and X-ray tube. Flat Detector and the X-ray control user interface) and the mobile viewing station (comprising the image processor, monitors, user interface for image/patient handling and optionally an integrated workstation).
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-Ray
Anatomical Site
Not Found
Indicated Patient Age Range
all patients except neonates (birth to 1 month)
Intended User / Care Setting
adequately trained, qualified, and authorized health care professionals such as physicians, surgeons, cardiologists, and radiographers. The device is to be used in healthcare facilities both inside and outside the operating room, in sterile as well as nonsterile environments, in a variety of procedures.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical performance testing has been performed on the proposed Veradius R1.2 and demonstrates compliance with International and FDA-recognized consensus standards and FDA guidance document.
The test results demonstrate that the proposed Veradius R1.2
- Complies with the aforementioned international and FDA-recognized consensus
- Meets the acceptance criteria and is adequate for its intended use.
- Image Quality is equal to the predicate.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1650 Image-intensified fluoroscopic x-ray system.
(a)
Identification. An image-intensified fluoroscopic x-ray system is a device intended to visualize anatomical structures by converting a pattern of x-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). An anthrogram tray or radiology dental tray intended for use with an image-intensified fluoroscopic x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. In addition, when intended as an accessory to the device described in paragraph (a) of this section, the fluoroscopic compression device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
K133819
Page 47 of 723 Page 1 of 3
510(k) Summary
JUL 1 0 2014
This 510(k) summary is prepared in accordance with 21 CFR 807.92.
....
| Date Prepared: | December 5, 2013 |
|---|---|
| Manufacturer: | Philips Medical Systems Nederland B.V. |
| Veenpluis 4-6 | |
| 5684 PC Best | |
| The Netherlands | |
| Establishment Registration Number: 3003768277 | |
| Contact Person: | Ruojuan Zhang |
| Regulatory Affairs Manager | |
| Phone: +31631685825 | |
| Fax: +31 40 2769100 | |
| E-mail: ruojuan.zhang@philips.com | |
| Device Name: | Veradius |
| Classification: | Classification Name: Interventional Fluoroscopic X-Ray System |
| Classification Regulation: 21 CFR892.1650 | |
| Classification Panel: Radiology | |
| Device Class: Class II | |
| Primary product code: OWB | |
| Secondary product code OXO | |
| Predicate Device | Trade Name: Veradius |
| Manufacturer: Philips Medical Systems Nederland B.V. | |
| 510(k) Clearance: K090590 (March 16, 2009) | |
| Classification Regulation: 21 CFR, Part 892.1650 | |
| Classification Name: Interventional Fluoroscopic X-Ray System | |
| Classification Panel: Radiology | |
| Device Class: Class II | |
| Product Code: OWB; JAA |
Device description:
The proposed Veradius R1.2 is a counterbalanced C-arm with a thin flat detector x-ray system. The system consists of two main component parts: the C-arm stand (comprising X-ray generator and X-ray tube. Flat Detector and the X-ray control user interface) and the mobile viewing station (comprising the image processor, monitors, user interface for image/patient handling and optionally an integrated workstation).
1
Indications for Use:
The proposed Veradius R1.2 device is intended to be used and operated by: adequately trained, qualified, and authorized health care professionals such as physicians, surgeons, cardiologists, radiologists, and radiographers, who have full understanding of the safety information and emergency procedures as well as the capabilities and functions of the device.
The device is used for radiological guidance and visualization during diagnostic, interventional, and surgical procedures on all patients except neonates (birth to 1 month), within the limits of the device. The device is to be used in healthcare facilities both inside and outside the operating room, in sterile as well as nonsterile environments, in a variety of procedures.
- Applications
- Orthopedic
- Neuro
- Abdominal
- Vascular
- · Thoracic
- · Cardiac
The proposed Philips Veradius R1.2 has identical indications to the currently marketed and predicate Veradius Mobile C-arm X-ray system (Veradius R1.1).
Technology:
The technology used in the development of the major components of the proposed Veradius R1.2 which includes X-ray generator, X-ray tube housing assembly, Image detection system and beam limiting device is identical to the currently marketed and predicate Veradius R1.1. The changes being proposed in this submission for the proposed Veradius R1.2, when compared to the currently marketed and predicate Veradius R1.1, are as follows:
- New C-arc geometry .
- Wireless LAN connection (without support of DHCP) .
- New Flat Detector(model: Pixium 2630Sv) .
- Additional display of dose information on Mobile Viewing Station .
- DICOM Structured Dose Reporting .
Based on the information provided in this premarket notification, the Veradius R1.2 is considered substantially equivalent to the currently marketed and predicate devices in terms of:
- � Indications for use;
- . Basic Design Features;
- Fundamental scientific technology; .
- . Operating Principle and control mechanism.
Non-clinical Performance Data:
Non-clinical performance testing has been performed on the proposed Veradius R1.2 and demonstrates compliance with International and FDA-recognized consensus standards and FDA guidance document.
- . IEC 60601-2-43 (2010)
- IEC 60601-2-28 (2010) .
- ISO 14971 (2007
- ISO 62304 (2006) �
- FDA Guidance document entitled, "Guidance for the Premarket ●
2
N133819
Page 3 of 3
Page 49 of 723
Submissions for Software Contained in Medical Devices" issued May 11, 2005.
- FDA Guidance document entitled, "Guidance for the Submission of . 510(k) 's for Solid State X-ray Imaging Devices '' issued August 6, 1999
- . FDA Guidance "Radio Frequency Wireless Technology in Medical Devices " issued August 14. 2013
Additionally, verification and validation tests have been performed to address intended use. the technical claims, requirement specifications, image quality and the risk management results.
The test results demonstrate that the proposed Veradius R1.2
- Complies with the aforementioned international and FDA-recognized . consensus
- . Meets the acceptance criteria and is adequate for its intended use.
- Image Quality is equal to the predicate. .
Therefore, the proposed Veradius R1.2 is substantially equivalent to the currently marketed and predicate device (K090590, March 16, 2009) in terms of safety and effectiveness.
The subject of this premarket submission, the Veradius R1.2 did not require Clinical Performance Data: clinical studies to support substantial equivalence.
Conclusion:
The proposed Veradius R1.2 are substantially equivalent to the currently marketed and predicate Veradius Mobile X-Ray system with regards to :
- � Indications for use;
- . Basic Design Features;
- Fundamental scientific technology: .
- Operating Principle and control mechanism. .
3
Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular arrangement of text surrounding a stylized symbol. The text reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular fashion. The symbol in the center resembles an abstract representation of an eagle or bird with three curved lines forming its body and wings.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hamoshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 10. 2014
Philips Medical Systems Nederland BV % Dr. Ruojuan Zhang Regulatory Affairs Manager Veenpluis 4-6 Best 5684 PC THE NETHERLAND
Rc: K133819
Trade/Device Name: Veradius Regulation Number: 21 CFR 892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: II Product Code: JAA, OWB Dated: April 3, 2014 Received: April 7, 2014
Dear Dr. Zhang:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (sec above) into cither class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA *s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820): and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.
4
Page 2-Dr. Zhang
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Smh.7)
for
Janine M. Morris Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known) K133819
Device Name Veradius
Indications for Use (Describe)
The Veradius device is intended to be used and operated by: adequately trained, qualified, and authorized health care professionals such as physicians, surgeons, cardiologists, and radiographers. who have full understanding of the safety information and emergency procedures as well as the capabilities and functions of the device. The device is used for radiological guidance and visualization during diagnostic, interventional, and surgical procedures on all patients except neonates (birth to 1 month), within the limits of the device is to be used in health care facilities both inside and outside the operating room. in sterile as well as nonsterile environments, in a variety of procedures.
Applications
- · Orthopedic
- · Neuro
- · Abdominal
- : Vascular
- · Thoracic
- · Cardiac
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
This section applies only to requirements of the Paperwork Reduction Act of 1995.
•DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."